Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes

Veronique Leblais, Su Hyun Jo, Khalid Chakir, Victor Maltsev, Ming Zheng, Michael T. Crow, Wang Wang, Edward Lakatta, Rui Ping Xiao

Research output: Contribution to journalArticle

Abstract

Phosphoinositide 3-kinase (PI3K) has been implicated in β2-adrenergic receptor (β2-AR)/G i-mediated compartmentation of the concurrent Gs-cAMP signaling, negating β2-AR-induced phospholamban phosphorylation and the positive inotropic and lusitropic responses in cardiomyocytes. However, it is unclear whether PI3K crosstalks with the β1-AR signal transduction, and even more generally, with the cAMP/PKA pathway. In this study, we show that selective β1-AR stimulation markedly increases PI3K activity in adult rat cardiomyocytes. Inhibition of PI3K by LY294002 significantly enhances β1-AR-induced increases in L-type Ca 2+ currents, intracellular Ca2+ transients, and myocyte contractility, without altering the receptor-mediated phosphorylation of phospholamban. The LY294002 potentiating effects are completely prevented by βARK-ct, a peptide inhibitor of β-adrenergic receptor kinase-1 (βARK1) as well as Gβγ signaling, but not by disrupting Gi function with pertussis toxin. Moreover, forskolin, an adenylyl cyclase activator, also elevates PI3K activity and inhibition of PI3K enhances forskolin-induced contractile response in a βARK-ct sensitive manner. In contrast, PI3K inhibition affects neither the basal contractility nor high extracellular Ca2+-induced increase in myocyte contraction. These results suggest that β1-AR stimulation activates PI3K via a PKA-dependent mechanism, and that Gβγ and the subsequent activation of βARK1 are critically involved in the PKA-induced PI3K signaling which, in turn, negates cAMP-induced positive inotropic effect via inhibiting sarcolemmal Ca2+ influx and the subsequent increase in intracellular Ca2+ transients, without altering the receptor-mediated phospholamban phosphorylation, in intact cardiomyocytes.

Original languageEnglish (US)
Pages (from-to)1183-1190
Number of pages8
JournalCirculation Research
Volume95
Issue number12
DOIs
StatePublished - Dec 10 2004

Fingerprint

Phosphatidylinositol 3-Kinase
1-Phosphatidylinositol 4-Kinase
Cardiac Myocytes
Adrenergic Receptors
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Phosphorylation
Colforsin
Muscle Cells
Phosphotransferases
Pertussis Toxin
Adenylyl Cyclases
Signal Transduction

Keywords

  • β- adrenergic receptor
  • Cardiac contractility
  • L-type calcium current
  • PI3K
  • PKA

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes. / Leblais, Veronique; Jo, Su Hyun; Chakir, Khalid; Maltsev, Victor; Zheng, Ming; Crow, Michael T.; Wang, Wang; Lakatta, Edward; Xiao, Rui Ping.

In: Circulation Research, Vol. 95, No. 12, 10.12.2004, p. 1183-1190.

Research output: Contribution to journalArticle

Leblais, Veronique ; Jo, Su Hyun ; Chakir, Khalid ; Maltsev, Victor ; Zheng, Ming ; Crow, Michael T. ; Wang, Wang ; Lakatta, Edward ; Xiao, Rui Ping. / Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes. In: Circulation Research. 2004 ; Vol. 95, No. 12. pp. 1183-1190.
@article{2037551795df4ff688d50e31d592661b,
title = "Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes",
abstract = "Phosphoinositide 3-kinase (PI3K) has been implicated in β2-adrenergic receptor (β2-AR)/G i-mediated compartmentation of the concurrent Gs-cAMP signaling, negating β2-AR-induced phospholamban phosphorylation and the positive inotropic and lusitropic responses in cardiomyocytes. However, it is unclear whether PI3K crosstalks with the β1-AR signal transduction, and even more generally, with the cAMP/PKA pathway. In this study, we show that selective β1-AR stimulation markedly increases PI3K activity in adult rat cardiomyocytes. Inhibition of PI3K by LY294002 significantly enhances β1-AR-induced increases in L-type Ca 2+ currents, intracellular Ca2+ transients, and myocyte contractility, without altering the receptor-mediated phosphorylation of phospholamban. The LY294002 potentiating effects are completely prevented by βARK-ct, a peptide inhibitor of β-adrenergic receptor kinase-1 (βARK1) as well as Gβγ signaling, but not by disrupting Gi function with pertussis toxin. Moreover, forskolin, an adenylyl cyclase activator, also elevates PI3K activity and inhibition of PI3K enhances forskolin-induced contractile response in a βARK-ct sensitive manner. In contrast, PI3K inhibition affects neither the basal contractility nor high extracellular Ca2+-induced increase in myocyte contraction. These results suggest that β1-AR stimulation activates PI3K via a PKA-dependent mechanism, and that Gβγ and the subsequent activation of βARK1 are critically involved in the PKA-induced PI3K signaling which, in turn, negates cAMP-induced positive inotropic effect via inhibiting sarcolemmal Ca2+ influx and the subsequent increase in intracellular Ca2+ transients, without altering the receptor-mediated phospholamban phosphorylation, in intact cardiomyocytes.",
keywords = "β- adrenergic receptor, Cardiac contractility, L-type calcium current, PI3K, PKA",
author = "Veronique Leblais and Jo, {Su Hyun} and Khalid Chakir and Victor Maltsev and Ming Zheng and Crow, {Michael T.} and Wang Wang and Edward Lakatta and Xiao, {Rui Ping}",
year = "2004",
month = "12",
day = "10",
doi = "10.1161/01.RES.0000150049.74539.8a",
language = "English (US)",
volume = "95",
pages = "1183--1190",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes

AU - Leblais, Veronique

AU - Jo, Su Hyun

AU - Chakir, Khalid

AU - Maltsev, Victor

AU - Zheng, Ming

AU - Crow, Michael T.

AU - Wang, Wang

AU - Lakatta, Edward

AU - Xiao, Rui Ping

PY - 2004/12/10

Y1 - 2004/12/10

N2 - Phosphoinositide 3-kinase (PI3K) has been implicated in β2-adrenergic receptor (β2-AR)/G i-mediated compartmentation of the concurrent Gs-cAMP signaling, negating β2-AR-induced phospholamban phosphorylation and the positive inotropic and lusitropic responses in cardiomyocytes. However, it is unclear whether PI3K crosstalks with the β1-AR signal transduction, and even more generally, with the cAMP/PKA pathway. In this study, we show that selective β1-AR stimulation markedly increases PI3K activity in adult rat cardiomyocytes. Inhibition of PI3K by LY294002 significantly enhances β1-AR-induced increases in L-type Ca 2+ currents, intracellular Ca2+ transients, and myocyte contractility, without altering the receptor-mediated phosphorylation of phospholamban. The LY294002 potentiating effects are completely prevented by βARK-ct, a peptide inhibitor of β-adrenergic receptor kinase-1 (βARK1) as well as Gβγ signaling, but not by disrupting Gi function with pertussis toxin. Moreover, forskolin, an adenylyl cyclase activator, also elevates PI3K activity and inhibition of PI3K enhances forskolin-induced contractile response in a βARK-ct sensitive manner. In contrast, PI3K inhibition affects neither the basal contractility nor high extracellular Ca2+-induced increase in myocyte contraction. These results suggest that β1-AR stimulation activates PI3K via a PKA-dependent mechanism, and that Gβγ and the subsequent activation of βARK1 are critically involved in the PKA-induced PI3K signaling which, in turn, negates cAMP-induced positive inotropic effect via inhibiting sarcolemmal Ca2+ influx and the subsequent increase in intracellular Ca2+ transients, without altering the receptor-mediated phospholamban phosphorylation, in intact cardiomyocytes.

AB - Phosphoinositide 3-kinase (PI3K) has been implicated in β2-adrenergic receptor (β2-AR)/G i-mediated compartmentation of the concurrent Gs-cAMP signaling, negating β2-AR-induced phospholamban phosphorylation and the positive inotropic and lusitropic responses in cardiomyocytes. However, it is unclear whether PI3K crosstalks with the β1-AR signal transduction, and even more generally, with the cAMP/PKA pathway. In this study, we show that selective β1-AR stimulation markedly increases PI3K activity in adult rat cardiomyocytes. Inhibition of PI3K by LY294002 significantly enhances β1-AR-induced increases in L-type Ca 2+ currents, intracellular Ca2+ transients, and myocyte contractility, without altering the receptor-mediated phosphorylation of phospholamban. The LY294002 potentiating effects are completely prevented by βARK-ct, a peptide inhibitor of β-adrenergic receptor kinase-1 (βARK1) as well as Gβγ signaling, but not by disrupting Gi function with pertussis toxin. Moreover, forskolin, an adenylyl cyclase activator, also elevates PI3K activity and inhibition of PI3K enhances forskolin-induced contractile response in a βARK-ct sensitive manner. In contrast, PI3K inhibition affects neither the basal contractility nor high extracellular Ca2+-induced increase in myocyte contraction. These results suggest that β1-AR stimulation activates PI3K via a PKA-dependent mechanism, and that Gβγ and the subsequent activation of βARK1 are critically involved in the PKA-induced PI3K signaling which, in turn, negates cAMP-induced positive inotropic effect via inhibiting sarcolemmal Ca2+ influx and the subsequent increase in intracellular Ca2+ transients, without altering the receptor-mediated phospholamban phosphorylation, in intact cardiomyocytes.

KW - β- adrenergic receptor

KW - Cardiac contractility

KW - L-type calcium current

KW - PI3K

KW - PKA

UR - http://www.scopus.com/inward/record.url?scp=10644241900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10644241900&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000150049.74539.8a

DO - 10.1161/01.RES.0000150049.74539.8a

M3 - Article

C2 - 15539636

AN - SCOPUS:10644241900

VL - 95

SP - 1183

EP - 1190

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 12

ER -